Fig. 4From: A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patientsResponse rates for the Brief Pain Inventory (BPI) average pain scores at the end of treatment. *p < 0.05 vs. placebo. Open bars, placebo; filled bars, duloxetineBack to article page